Taxanes in adjuvant and neoadjuvant therapy for breast cancer

OpuholiŽenskoj Reproduktivnoj Sistemy

S. V. Limareva¹ 

[1] Department of Chemotherapy, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow;

关键词: breast cancer;    adjuvant chemotherapy;    taxanes;    objective effect;    relapse-free and overall survival;   

DOI  :  10.17650/1994-4098-2010-0-4-15-23

来源: DOAJ

【 摘 要 】

Taxanes (paclitaxel and docetaxel) are currently considered to be basic cytostatics in the treatment of all breast cancer (BC) stages. The results of conducted and ongoing clinical trials suggest that incorporation of taxanes into adjuvant and neoadjuvant chemotherapy regimens enhances the efficiency of treatment for operable BC and show it necessary to apply an individual approach depending on prognostic and predictive factors.

【 授权许可】

Unknown